RECURRENT MARGINAL ZONE LYMPHOMA

Clinical trials for RECURRENT MARGINAL ZONE LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT MARGINAL ZONE LYMPHOMA trials appear

Sign up with your email to follow new studies for RECURRENT MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 12 Completed 1

New engineered immune cell therapy enters first human trials for aggressive blood cancers

Disease control Recruiting now

This is an early-stage study testing a new type of personalized cell therapy called MC10029 for adults with B-cell blood cancers that have come back or stopped responding to standard treatments. Researchers will first find the safest dose and then see if the therapy can shrink tu…

Matched conditions: RECURRENT MARGINAL ZONE LYMPHOMA

Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Mar 27, 2026 12:37 UTC

RECURRENT MARGINAL ZONE LYMPHOMA

Get alerted when new RECURRENT MARGINAL ZONE LYMPHOMA trials appear

New engineered immune cell therapy enters first human trials for aggressive blood cancers